跳至主要内容
临床试验/NCT00821860
NCT00821860已完成3 期

Prospective Randomised Controlled Trial of Video-Assisted Thoracoscopic (VAT) Cytoreductive Pleurectomy Compared to Talc Pleurodesis in Patients With Suspected or Proven Malignant Mesothelioma

Papworth Hospital NHS Foundation Trust10 个研究点 分布在 1 个国家目标入组 196 人开始时间: 2003年9月最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
196
试验地点
10
主要终点
Survival at 1 year after treatment

研究概览

简要总结

RATIONALE: Video-assisted surgery to remove part of the tissue layer covering the inside of the chest cavity may be effective in treating pleural effusion and cause less damage to normal tissue. Talc pleurodesis may keep fluid from building up in the chest cavity. It is not yet known which therapy is more effective in treating pleural effusion caused by malignant mesothelioma.

PURPOSE: This randomized phase III trial is studying video-assisted surgery to see how well it works compared with talc pleurodesis in treating patients with malignant mesothelioma.

详细描述

OBJECTIVES:

Primary

  • Compare the effectiveness of video-assisted thoracoscopic cytoreductive pleurectomy vs talc pleurodesis, in terms of 1-year survival, in patients with suspected or proven malignant mesothelioma.

Secondary

  • Compare the control of pleural effusion in these patients.
  • Compare procedure-related complications in these patients.
  • Compare the symptoms and quality of life of these patients at 3, 6, and 12 months after treatment.
  • Compare the length of hospital stay for these patients.
  • Compare the exercise tolerance of these patients at 3, 6, and 12 months after treatment.
  • Determine the cost to the health service, in terms of resources used for procedures, hospital bed usage, and cost of primary and secondary care over 12 months.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Survival at 1 year after treatment

时间窗: 1 year

次要结局

  • Control of pleural effusion(1 year)
  • Complications, including need for more surgery, persistent air leak requiring pleural intubation for > 10 days, and hospital stay for > 12 days(1 year)
  • Symptoms and quality of life as assessed by the EuroQol questionnaire(0, 1, 3, 6 12 months)
  • Length of hospital stay(1 year)
  • Exercise tolerance(0, 1, 3, 6 12 months)
  • Cost to the health service, in terms of resources used for procedures, hospital bed usage, and cost of primary and secondary care over 12 months(0, 1, 3, 6 12 months)

研究者

申办方类型
Other Gov
责任方
Sponsor

研究点 (10)

Loading locations...

相似试验